Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

γδ T cells are crucial for early wound healing after a skin virus infection.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

CDK4 levels affect the number of hair follicle stem cells in mice.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Clonally expanded CD8+ T cells cause alopecia areata.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Gamma/delta T cells help defend skin against heavy metals.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

A new mouse model helps study melanocyte cells using GFP expression.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.